Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
To access the live conference call, U.S. and Canadian participants maydial +1-866-966-5335; international participants may dial +44-20-3023-4460.To access the 24-hour audio replay, U.S. and Canadian participants may dial+1-866-583-1035; international participants may dial +44-20-8196-1998. Theaccess code for the replay is 181543#. The replay will be available until May28, 2008.
A live audio webcast of the call will also be available on the"Investors" section of the company's website, http://www.RosettaGenomics.com.An archived webcast will be available on the Company's website approximatelytwo hours after the event, and will be archived for 30 days thereafter.
About Rosetta Genomics
Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNA.Founded in 2000, the company's integrative research platform combiningbioinformatics and state-of-the-art laboratory processes has led to thediscovery of hundreds of biologically validated novel human microRNAs .Building on its strong IP position and proprietary platform technologies,Rosetta Genomics is working on the application of these technologies in thedevelopment of a full range of microRNA-based diagnostic and therapeutictools, focusing primarily on cancer and various women's health indications.The company expects that the first microRNA diagnostic tests applying itstechnology will be launched by licensed clinical laboratories in the UnitedStates in 2008.Contact: Media Rachel Spielman T: +1-212-583-271 E: firstname.lastname@example.org Investors Ron Kamienchick T: +1-646-509-1893 E: email@example.com
SOURCE Rosetta Genomics Ltd
You May Also Like